Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M105,267Revenue (TTM) $M25,638Net Margin (%)23.2Altman Z-Score2.1
Enterprise Value $M135,686EPS (TTM) $3.6Operating Margin %36.6Piotroski F-Score6
P/E(ttm)18.1Beneish M-Score-2.4Pre-tax Margin (%)30.8Higher ROA y-yN
Price/Book23.010-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsY
Price/Sales4.25-y EBITDA Growth Rate %9.5Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow16.3y-y EBITDA Growth Rate %23.9ROA % (ttm)9.7Higher Current Ratio y-yY
Dividend Yield %3.7PEG1.9ROE % (ttm)117Less Shares Outstanding y-yY
Payout Ratio %63.0Shares Outstanding M1,594ROIC % (ttm)21.9Gross Margin Increase y-yN

Gurus Latest Trades with ABBV

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ABBV is held by these investors:



ABBV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Michael Robert A.VP, Controller 2017-03-10Sell5,132$65.29-0.66view
Schumacher Laura JExecutive Vice President 2017-03-10Sell40,000$65.26-0.61view
RICHMOND TIMOTHY J.SVP, Human Resources 2017-03-10Sell22,451$65.29-0.66view
GONZALEZ RICHARD AChairman of the Board and CEO 2017-03-08Sell72,016$64.250.95view
HURWICH THOMAS A.VP, Controller 2017-02-28Sell2,311$61.894.8view
CHASE WILLIAM JEVP, CFO 2016-12-02Sell6,600$59.199.58view
HURWICH THOMAS A.VP, Controller 2016-11-16Sell3,100$624.61view
Schumacher Laura JExecutive Vice President 2016-09-07Sell50,000$65-0.22view
Schumacher Laura JExecutive Vice President 2016-06-24Sell186,106$60.038.05view
GONZALEZ RICHARD AChairman of the Board and CEO 2016-06-02Sell285,953$63.821.63view

Press Releases about ABBV :

Quarterly/Annual Reports about ABBV:

News about ABBV:

Articles On GuruFocus.com
AbbVie's Veliparib Missed Primary Endpoints of 2 Clinical Trials Apr 21 2017 
AbbVie to Present at the Deutsche Bank 42nd Annual Health Care Conference Apr 21 2017 
Eight Weeks of Treatment with AbbVie's Investigational, Pan-Genotypic Regimen of Glecaprevir/Pibrent Apr 21 2017 
AbbVie's Investigational, Pan-Genotypic, Ribavirin-free Regimen of Glecaprevir/Pibrentasvir (G/P) Ac Apr 20 2017 
The Better Big Pharma Stock: AbbVie or Gilead? Apr 18 2017 
FDA Rejects Eli Lilly, Incyte's Commercialization Application Apr 18 2017 
Humira Fears Likely Overblown; Strong Total Returns Ahead Apr 11 2017 
AbbVie Announces Positive Phase 2b Data Demonstrating Investigational Medicine Elagolix Significantl Apr 07 2017 
AbbVie to Host First-Quarter Earnings Conference Call Apr 06 2017 
FDA Grants AbbVie Review for Imbruvica Apr 05 2017 

More From Other Websites
3 Dividend Stocks That Investors Should Love Apr 23 2017
Better Buy: AbbVie Inc. vs. Pfizer Apr 22 2017
Cramer's lightning round: This drug stock is simply not good enough for your portfolio Apr 21 2017
AbbVie (ABBV) Presents Positive Data on HCV Combination Drug Apr 21 2017
What's in Store for AbbVie (ABBV) this Earnings Season? Apr 21 2017
Blog Coverage AbbVie's HCV Regimen Achieves 99% Cure Rate in Phase III Study Apr 21 2017
AbbVie to Present at the Deutsche Bank 42nd Annual Health Care Conference Apr 21 2017
Eight Weeks of Treatment with AbbVie's Investigational, Pan-Genotypic Regimen of... Apr 21 2017
AbbVie, Inc. – Value Analysis (NYSE:ABBV) : April 20, 2017 Apr 20 2017
Failure Of Abbvie's Cancer Drug Hasn't Hurt The Stock Apr 20 2017
AbbVie's PARP Inhibitor Comes Up Empty Apr 20 2017
AbbVie's (ABBV) Cancer Candidate Fails in Phase III Studies Apr 20 2017
AbbVie's Investigational, Pan-Genotypic, Ribavirin-free Regimen of Glecaprevir/Pibrentasvir (G/P)... Apr 20 2017
AbbVie cancer drug fails two late-stage trials Apr 19 2017
AbbVie, Inc. breached its 50 day moving average in a Bearish Manner : ABBV-US : April 19, 2017 Apr 19 2017
Top 4 Medicinal Marijuana Stocks to Watch for 2017 Apr 19 2017
Dow's Johnson & Johnson Highlights 'Multiple Issues' For Drugs, Biotechs Apr 18 2017
Is AbbVie a Great Dividend Stock for Your Portfolio? Apr 18 2017
The Better Big Pharma Stock: AbbVie or Gilead? Apr 18 2017
High-Yield Healthcare Investments You Can Buy Right Now Apr 18 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)